Literature DB >> 1647362

Secretion of biologically active leech hirudin from baculovirus-infected insect cells.

L Benatti1, E Scacheri, D H Bishop, P Sarmientos.   

Abstract

The thrombin inhibitor, hirudin, from the leech Hirudo Medicinalis, is the most powerful natural anticoagulant known. It has been characterized as a polypeptide of 65 amino acids which exhibits its anticoagulant properties by binding tightly and specifically to alpha-thrombin. The potency and specificity of hirudin have generated interest on its possible use in the treatment or prophylaxis of various thrombotic diseases. We have used the baculovirus expression system to efficiently produce active hirudins in insect cells. The Autographa californica nuclear polyhedrosis virus has proved useful as a helper-independent viral expression vector for high-level production of recombinant proteins in cultured insect cells. Hirudin variants (HV1 and HV2) were produced in infected insect cells as secreted proteins by joining their coding sequences to the leader peptide sequence of the vescicular stomatitis virus G protein. The recombinant products were biologically active and, interestingly, N-terminal sequencing of HV1 revealed that the heterologous leader peptide is correctly removed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647362     DOI: 10.1016/0378-1119(91)90420-g

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

Review 1.  The use of baculoviruses as expression vectors.

Authors:  I M Kidd; V C Emery
Journal:  Appl Biochem Biotechnol       Date:  1993 Aug-Sep       Impact factor: 2.926

2.  Production of biologically active hirudin in plant seeds using oleosin partitioning.

Authors:  D L Parmenter; J G Boothe; G J van Rooijen; E C Yeung; M M Moloney
Journal:  Plant Mol Biol       Date:  1995-12       Impact factor: 4.076

3.  Cell-free synthesis of the hirudin variant 1 of the blood-sucking leech Hirudo medicinalis.

Authors:  Doreen A Wüstenhagen; Phil Lukas; Christian Müller; Simone A Aubele; Jan-Peter Hildebrandt; Stefan Kubick
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.